KSC Equity Snapshot
185750 Weekly Equity Report
Chong Kun Dang Pharmaceutical Corp.
What the company does
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
What the weekly tape is saying
185750 closed the latest completed week at 70,800 KRW. The 4-week return is -12.8% and the 12-week return is -20.2%. Trend Signal is inactive, Market Dynamics is -1.20. Setup signature: Risk-first tape with a 21/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 85,615 KRW
- Vs Trend Line
- -17.3%
- Fair Value
- 89,790 KRW
- Vs Fair Value
- -21.1%
- 52W High
- 106,175 KRW
- 52W Low
- 67,900 KRW
- Drawdown
- -33.3%
- Range Position
- 7.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 28
- 52W Active Breadth
- 53.8%
- Sector Scope
- KR Healthcare
- Sector Rank
- 55 of 63
- Sector Percentile
- 12.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 33 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 22 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.20
- 4W MD Change
- -37.2%
- Relative Strength
- -55.33
- 4W RS Change
- -13.4%
- Expectation
- Undecided
- Probability
- 50.52%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 183.2K
- 13W Average
- 144.1K
- 52W Average
- 181.7K
- Vs 13W
- 1.3x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.2%
- 52W Volatility
- 3.6%
- Upside Weeks
- 21
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 3.1% / -2.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 1021.1B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 70,800 KRW | -4.8% | 85,615 KRW | 89,790 KRW | -1.20 | -55.33 | 183.2K | Off |
| 5 Jun 2026 | 74,400 KRW | -6.3% | 86,128 KRW | 89,811 KRW | -1.20 | -54.21 | 129.7K | Off |
| 29 May 2026 | 79,400 KRW | -0.8% | 86,379 KRW | 89,831 KRW | -1.15 | -53.89 | 163.0K | Off |
| 22 May 2026 | 80,000 KRW | -1.5% | 86,476 KRW | 89,824 KRW | -1.11 | -50.87 | 130.5K | Off |
| 15 May 2026 | 81,200 KRW | -1.9% | 86,484 KRW | 89,799 KRW | -0.87 | -48.81 | 176.0K | Off |
| 8 May 2026 | 82,800 KRW | -3.4% | 86,445 KRW | 89,761 KRW | -0.59 | -48.77 | 132.9K | Off |
| 1 May 2026 | 85,700 KRW | -3.9% | 86,369 KRW | 89,713 KRW | -0.39 | -40.77 | 102.7K | On |
| 24 Apr 2026 | 89,200 KRW | -1.2% | 86,240 KRW | 89,654 KRW | -0.16 | -38.19 | 101.2K | On |
| 17 Apr 2026 | 90,300 KRW | 3.4% | 85,911 KRW | 89,562 KRW | 0.03 | -35.50 | 159.2K | On |
| 10 Apr 2026 | 87,300 KRW | -1.0% | 85,867 KRW | 89,457 KRW | 0.03 | -35.04 | 135.8K | On |
| 3 Apr 2026 | 88,200 KRW | -3.8% | 85,671 KRW | 89,388 KRW | 0.02 | -29.47 | 151.4K | On |
| 27 Mar 2026 | 91,700 KRW | 3.4% | 85,422 KRW | 89,295 KRW | 0.04 | -28.39 | 151.3K | On |
| 20 Mar 2026 | 88,700 KRW | 4.2% | 85,013 KRW | 89,146 KRW | 0.27 | -35.56 | 156.3K | On |
| 13 Mar 2026 | 85,100 KRW | -0.6% | 84,747 KRW | 89,016 KRW | 0.58 | -35.63 | 135.5K | On |